Cargando…

Caution, “normal” BMI: health risks associated with potentially masked individual underweight—EPMA Position Paper 2021

An increasing interest in a healthy lifestyle raises questions about optimal body weight. Evidently, it should be clearly discriminated between the standardised “normal” body weight and individually optimal weight. To this end, the basic principle of personalised medicine “one size does not fit all”...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golubnitschaja, Olga, Liskova, Alena, Koklesova, Lenka, Samec, Marek, Biringer, Kamil, Büsselberg, Dietrich, Podbielska, Halina, Kunin, Anatolij A., Evsevyeva, Maria E., Shapira, Niva, Paul, Friedemann, Erb, Carl, Dietrich, Detlef E., Felbel, Dieter, Karabatsiakis, Alexander, Bubnov, Rostyslav, Polivka, Jiri, Birkenbihl, Colin, Fröhlich, Holger, Hofmann-Apitius, Martin, Kubatka, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368050/ https://www.ncbi.nlm.nih.gov/pubmed/34422142 http://dx.doi.org/10.1007/s13167-021-00251-4

Ejemplares similares

The activities of the young professionals EPMA in the Czech Republic
por: Polivka Jr , Jiri, et al.
Publicado: (2014)

Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person
por: Koklesova, Lenka, et al.
Publicado: (2021)

“Pre-metastatic niches” in breast cancer: are they created by or prior to the tumour onset? “Flammer Syndrome” relevance to address the question
por: Bubnov, Rostyslav, et al.
Publicado: (2017)

Carotenoids in Cancer Metastasis—Status Quo and Outlook
por: Koklesova, Lenka, et al.
Publicado: (2020)

Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects—the evidence-based 3PM proposition to mitigate individual risks
por: Liskova, Alena, et al.
Publicado: (2021)

Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells
por: Mazurakova, Alena, et al.
Publicado: (2023)

Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine
por: Koklesova, Lenka, et al.
Publicado: (2021)

Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine — comprehensive effects of phytochemicals in primary, secondary and tertiary care
por: Mazurakova, Alena, et al.
Publicado: (2022)

Phytochemical-based nanodrugs going beyond the state-of-the-art in cancer management—Targeting cancer stem cells in the framework of predictive, preventive, personalized medicine
por: Koklesova, Lenka, et al.
Publicado: (2023)

Mitochondriopathies as a Clue to Systemic Disorders—Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine
por: Liskova, Alena, et al.
Publicado: (2021)

Liquid Biopsy is Instrumental for 3PM Dimensional Solutions in Cancer Management
por: Liskova, Alena, et al.
Publicado: (2020)

Protective Effects of Flavonoids Against Mitochondriopathies and Associated Pathologies: Focus on the Predictive Approach and Personalized Prevention
por: Koklesova, Lenka, et al.
Publicado: (2021)

Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016
por: Golubnitschaja, Olga, et al.
Publicado: (2016)

Mitochondrial health quality control: measurements and interpretation in the framework of predictive, preventive, and personalized medicine
por: Koklesova, Lenka, et al.
Publicado: (2022)

Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
por: Samuel, Samson Mathews, et al.
Publicado: (2020)

Carotenoids in Cancer Apoptosis—The Road from Bench to Bedside and Back
por: Koklesova, Lenka, et al.
Publicado: (2020)

Metabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects
por: Samec, Marek, et al.
Publicado: (2021)

Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation
por: Kropp, Martina, et al.
Publicado: (2023)

Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer
por: Abu Samaan, Tala M., et al.
Publicado: (2019)

Anticancer Potential of Lichens’ Secondary Metabolites
por: Solárová, Zuzana, et al.
Publicado: (2020)

Flavonoids in Cancer Metastasis
por: Liskova, Alena, et al.
Publicado: (2020)

Antithrombotic and antiplatelet effects of plant-derived compounds: a great utility potential for primary, secondary, and tertiary care in the framework of 3P medicine
por: Kubatka, Peter, et al.
Publicado: (2022)

Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
por: Varghese, Elizabeth, et al.
Publicado: (2020)

Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine
por: Koklesova, Lenka, et al.
Publicado: (2020)

Cell-free nucleic acid patterns in disease prediction and monitoring—hype or hope?
por: Crigna, Adriana Torres, et al.
Publicado: (2020)

Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression—3PM pathways
por: Kubatka, Peter, et al.
Publicado: (2021)

Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles
por: Liskova, Alena, et al.
Publicado: (2021)

Dental health: EPMA recommendations for innovative strategies
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

EPMA position paper in cancer: current overview and future perspectives
por: Grech, Godfrey, et al.
Publicado: (2015)

EPMA-World Congress 2015: Bonn, Germany. 3-5 September 2015
por: Abraham, Jella-Andrea, et al.
Publicado: (2016)

Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach
por: Golubnitschaja, Olga, et al.
Publicado: (2022)

Calcium Entry through TRPV1: A Potential Target for the Regulation of Proliferation and Apoptosis in Cancerous and Healthy Cells
por: Zhai, Kevin, et al.
Publicado: (2020)

Therapeutic Potential of Plant Phenolic Acids in the Treatment of Cancer
por: Abotaleb, Mariam, et al.
Publicado: (2020)

Flavonoids Synergistically Enhance the Anti-Glioblastoma Effects of Chemotherapeutic Drugs
por: Zhai, Kevin, et al.
Publicado: (2021)

Immunomodulation by Gut Microbiome on Gastrointestinal Cancers: Focusing on Colorectal Cancer
por: AL-Ishaq, Raghad Khalid, et al.
Publicado: (2022)

Cold Atmospheric Pressure Plasma (CAP) as a New Tool for the Management of Vulva Cancer and Vulvar Premalignant Lesions in Gynaecological Oncology
por: Zubor, Pavol, et al.
Publicado: (2020)

Anti-breast cancer effects of phytochemicals: primary, secondary, and tertiary care
por: Mazurakova, Alena, et al.
Publicado: (2022)

Fluctuations of Histone Chemical Modifications in Breast, Prostate, and Colorectal Cancer: An Implication of Phytochemicals as Defenders of Chromatin Equilibrium
por: Samec, Marek, et al.
Publicado: (2019)

Enzymatic Metabolism of Flavonoids by Gut Microbiota and Its Impact on Gastrointestinal Cancer
por: AL-Ishaq, Raghad Khalid, et al.
Publicado: (2021)

miRNA Expression Profiles in Luminal A Breast Cancer—Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment
por: Kudela, Erik, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i3lhi2h3ppupajvb0h31643tbo